Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity

C Salvagno, JK Mandula, PC Rodriguez… - Trends in cancer, 2022 - cell.com
The tumor microenvironment (TME) provokes endoplasmic reticulum (ER) stress in
malignant cells and infiltrating immune populations. Sensing and responding to ER stress is …

PTEN dual lipid-and protein-phosphatase function in tumor progression

A Liu, Y Zhu, W Chen, G Merlino, Y Yu - Cancers, 2022 - mdpi.com
Simple Summary Phosphatase and tensin homolog deleted on chromosome ten (PTEN) is a
multifunctional tumor suppressor with protein-and lipid-phosphatase activities. The …

Tumor Cell Resistance to the Inhibition of BRAF and MEK1/2

W Chen, JI Park - International Journal of Molecular Sciences, 2023 - mdpi.com
BRAF is one of the most frequently mutated oncogenes, with an overall frequency of about
50%. Targeting BRAF and its effector mitogen-activated protein kinase kinase 1/2 (MEK1/2) …

Development of Personalized Strategies for Precisely Battling Malignant Melanoma

AJ Isaak, GGR Clements, RGM Buenaventura… - International Journal of …, 2024 - mdpi.com
Simple Summary Precision oncology is emerging as a viable option to improve survival in
patients who fail to remain disease-free even after the employment of currently available …

PTEN phosphatase inhibits metastasis by negatively regulating the Entpd5/IGF1R pathway through ATF6

Y Yu, M Dai, L Huang, W Chen, E Yu, A Mendoza… - Iscience, 2023 - cell.com
PTEN encodes a tumor suppressor with lipid and protein phosphatase activities whose
dysfunction has been implicated in melanomagenesis; less is known about how its …

PTEN as a target in melanoma

FA Ince, A Shariev, K Dixon - Journal of Clinical Pathology, 2022 - jcp.bmj.com
PTEN is a well-known tumour suppressor protein that is frequently found to be mutated,
inactivated or deleted in a wide range of different cancers. Its tumour suppressive properties …

Potential biomarkers of skin melanoma resistance to targeted therapy—present state and perspectives

M Olbryt - Cancers, 2022 - mdpi.com
Simple Summary Around 5–10% of advanced melanoma patients progress early on anti-
BRAF targeted therapy and 20–30% respond only with the stabilization of the disease …

[HTML][HTML] DNAJC10 maintains survival and self-renewal of leukemia stem cells through PERK branch of the unfolded protein response

M Li, X Wu, M Chen, S Hao, Y Yu, X Li, E Zhao… - …, 2024 - ncbi.nlm.nih.gov
Leukemia stem cells (LSC) require frequent adaptation to maintain their self-renewal ability
in the face of longer exposure to cell-intrinsic and cell-extrinsic stresses. However, the …

Exploring and validating the metastasis mechanism of pathenolide interfering with cutaneous melanoma through ER stress‐dependent apoptosis based on the …

L Liu, N Liu, H Zhang, D Li - Phytochemical Analysis, 2023 - Wiley Online Library
Background This study aimed to explore the mechanism of parthenolide in inhibiting
melanoma metastasis through network pharmacology and cell experiment. Materials and …

[HTML][HTML] Гены CCND1 и PTEN как маркеры прогрессирования при раке вульвы

АВ Бусарова, НА Петрусенко, ПА Крузе… - Research'n Practical …, 2023 - cyberleninka.ru
Цель исследования. Изучение относительной копийности 12 генов: MYC, PTEN,
CCND1, PIK3CA, TP53, CDKN2A, MDM2, MCL1, NFKBIA, MTAP, BIRC2, KMT2C для …